Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder

Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time follo…